Meanwhile, GFPT2 plays a critical role in tumor metabolic reprogramming in lung cancer [137], acts as a neoplastic marker in tenosynovial giant cell tumors (TGCT) [138], and functions as an androgen receptor-inducible target involved in prostate cancer metabolic reprogramming [42]. This evidence concerns the gene GFPT2 and lung carcinoma.